Log In
BCIQ
Print this Print this
 

NXN-188

Also known as: nNOS/5HT

  Manage Alerts
Collapse Summary General Information
Company Knight Therapeutics Inc.
DescriptionSmall molecule neuronal nitric oxide synthase (nNOS) inhibitor and serotonin (5-HT) receptor agonist
Molecular Target Neuronal nitric oxide synthase 1 (NOS1) (nNOS) ; Serotonin (5-HT) receptor
Mechanism of ActionNitric oxide (NO) synthase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationMigraine
Indication DetailsTreat acute migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today